← BLACKLEDGER Content Feed

Buying • NEUROPHAGE x BLACKLEDGER • 8 min read • 2026-08-12

BLACKLEDGER Buying Watch: NEAR, ZAR/JPY, ANET

BLACKLEDGERMarket ResearchBuyingNEARZAR/JPYANETUBER
BLACKLEDGER Buying public market research update for NEAR, ZAR/JPY, ANET

BLACKLEDGER's latest buying watch update tracks NEAR, ZAR/JPY, ANET, UBER, INTC, ABOS from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.

Buying Watch Data

The dedicated feed category for this update is Buying. The latest public scan timestamp is 2026-08-12T08:00:48.694653+00:00.

Educational Context: How To Use This Page

This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.

NEAR Public Research Bio

Name: NEAR Protocol USD. Market class: crypto. Public bias: Bull. Public tier: Extended.

NEAR Protocol (NEAR) is a cryptocurrency launched in 2020. NEAR Protocol has a current supply of 1,303,358,708. The last known price of NEAR Protocol is 1.6515307 USD and is up 2.82 over the last 24 hours. It is currently trading on 656 active market(s) with $194,830,759.35 traded over the last 24 hours. More information can be found at https://near.org/.

Why NEAR Is In This Public Update

Outside Public Headlines / Source Notes

ZAR/JPY Public Research Bio

Name: ZAR/JPY. Market class: forex. Public bias: Bull. Public tier: Extended.

Outside-source profile data was limited for this asset at publication time, so this section focuses on public BLACKLEDGER status data and verified public market context.

Why ZAR/JPY Is In This Public Update

Outside Public Headlines / Source Notes

ANET Public Research Bio

Name: Arista Networks, Inc.. Market class: stock. Public bias: Bull. Public tier: Extended.

Arista Networks, Inc. engages in the development, marketing, and sale of data-driven, client to cloud networking solutions for AI, data center, campus, and routing environments in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. Its cloud networking solutions consist of Extensible Operating System (EOS), a publish-subscribe state-sharing networking operating system offered in combination with a set of network applications. The company offers data center, cloud and AI networking, cognitive adjacencies, and cognitive network software and services. It also provides post contract customer support services, such as technical support, hardware repair and replacement parts beyond standard warranty, bug fixes, patches, and upgrade services. The company serves a range of industries comprising internet companies, cloud service providers, financial services organizations, government agencies, media and entertainment, healthcare

Why ANET Is In This Public Update

Outside Public Headlines / Source Notes

UBER Public Research Bio

Name: Uber Technologies, Inc.. Market class: stock. Public bias: Bull. Public tier: Extended.

Uber Technologies, Inc. develops and operates proprietary technology applications in the United States, Canada, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Mobility, Delivery, and Freight. The Mobility segment connects consumers with a range of transportation modalities, such as ridesharing, carsharing, micromobility, rentals, public transit, taxis, and other modalities; and offers riders in a variety of vehicle types, as well as financial partnerships products and advertising services. The Delivery segment allows consumers to search for and discover restaurants to grocery, alcohol, convenience, and other retailers, as well as order a meal or other items, and either pick-up at the restaurant or have it delivered; and provides Uber direct, a white-label delivery-as-a-service for retailers and restaurants, as well as advertising services. The Freight segment manages tr

Why UBER Is In This Public Update

Outside Public Headlines / Source Notes

INTC Public Research Bio

Name: Intel Corporation. Market class: stock. Public bias: Bull. Public tier: Extended.

Intel Corporation designs, develops, manufactures, markets, sells, and services computing and related end products and services in the United States, Ireland, Israel, and internationally. It operates through three segments: CCG, DCAI, and Intel Foundry. The company offers client computing group products, including client and commercial CPUs, discrete client GPUs, edge computing, and connectivity products; data center and AI products, such as server CPUs, discrete GPUs, and networking products; and semiconductors comprising wafer fabrication, substrates, and other related products and services. It also provides driving assistance and self-driving solutions; and develops and manufactures multi-beam mask writing tools. The company sells its products through sales organizations, distributors, resellers, retailers, and OEM partners. It serves original equipment manufacturers, original design manufacturers, cloud service providers, and other

Why INTC Is In This Public Update

Outside Public Headlines / Source Notes

ABOS Public Research Bio

Deep bio flag: This asset reached the 9+ public rating threshold, so BLACKLEDGER includes a fuller company/project profile, outside-source context, and public education notes.

Name: Acumen Pharmaceuticals, Inc.. Market class: stock. Public bias: Bull. Public tier: Extended.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug, as well as with JCR Pharmaceuticals Co. Ltd for the development of Aß oligomer-targeted enhanced brain delivery therapy for the treatment of Alzheimer's disease. The company was incorporated in 1996 and is headquartered in Newton, Massachusetts.

Why ABOS Is In This Public Update

Outside Public Headlines / Source Notes

What The Public Data Shows

The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.

Why This Category Matters

The Buying section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.

Research-Only Notice

BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.

Research-only. No execution signal. Not financial advice.